Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-022649

Director bought 69,000 shares at $4.98 ($343,620)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-29 Purchase : show line 1 in the form +69,000 $4.98 $343,620 4,918,286 I
Open-market purchases · 69,000 sh · avg $4.98 · $343,620
Loading xslF345X03/doc1.xml…